As part of a test of instruments publicly funded by the federal and state governments, the LSI has developed and validated a large number of concepts for a promising transfer of life science projects to the economy. The intensive evaluation and concept optimization carried out by the LSI turned out to be goal-oriented, with its questions addressing the greatest hurdle of investment attractiveness at the beginning of a development process. How high is the potential of a technology, where is the previous development plan not promising, Is there a convincing property rights strategy and does the founding team not only have know-how but also perseverance? The focus of a life science idea on the later exploitation is ultimately decisive for the commitment of private investors and industrial partners and thus also for the sustainable future of a start-up.
Since 2008, the Life Science Incubator has viewed around 1,000 ideas and intensively assessed more than 400 of them. This included projects from stem cell research, biomarker development or phage therapy as well as bioresorbable spinal implants, hybrid technology for wheelchairs or biomedical sensor developments.
During the instrument testing phase, this concept was evaluated and given a positive rating by both Ernst & Young and Rambøll. In the next phase, the collected know-how should now benefit a larger number of life science start-up projects from universities and colleges.